These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17483121)

  • 1. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.
    Barton HA; Chiu WA; Setzer RW; Andersen ME; Bailer AJ; Bois FY; Dewoskin RS; Hays S; Johanson G; Jones N; Loizou G; Macphail RC; Portier CJ; Spendiff M; Tan YM
    Toxicol Sci; 2007 Oct; 99(2):395-402. PubMed ID: 17483121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and specification of physiologically based pharmacokinetic models for use in risk assessment.
    Clewell RA; Clewell HJ
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):129-43. PubMed ID: 18077066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of physiologically based pharmacokinetic models for use in risk assessment.
    Chiu WA; Barton HA; DeWoskin RS; Schlosser P; Thompson CM; Sonawane B; Lipscomb JC; Krishnan K
    J Appl Toxicol; 2007; 27(3):218-37. PubMed ID: 17299829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for applications of physiologically based pharmacokinetic models in risk assessment.
    Thompson CM; Sonawane B; Barton HA; DeWoskin RS; Lipscomb JC; Schlosser P; Chiu WA; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2008 Aug; 11(7):519-47. PubMed ID: 18584453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.
    Chiu WA; Okino MS; Evans MV
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):36-60. PubMed ID: 19660485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps.
    Loizou G; Spendiff M; Barton HA; Bessems J; Bois FY; d'Yvoire MB; Buist H; Clewell HJ; Meek B; Gundert-Remy U; Goerlitz G; Schmitt W
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):400-11. PubMed ID: 18331772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.
    Clark LH; Setzer RW; Barton HA
    Risk Anal; 2004 Dec; 24(6):1697-717. PubMed ID: 15660623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
    Valcke M; Krishnan K
    J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty and variability in the exposure reconstruction of chemical incidents--the case of acrylonitrile.
    Huizer D; Ragas AM; Oldenkamp R; van Rooij JG; Huijbregts MA
    Toxicol Lett; 2014 Dec; 231(3):337-43. PubMed ID: 25050995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
    Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
    Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
    Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.